ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
A Feasibility Study to Evaluate the Safety and Initial Effectiveness of ExAblate MR Guided Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
Sponsor: InSightec
Terminated
Terminated due to low enrollment.
Other terminated trials from InSightec
Other Bone Metastases trials with similar outcome
Listed as NCT00981578, this NA trial focuses on Bone Metastases and remains terminated or withdrawn. Sponsored by InSightec, it has been updated 11 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Apr 2020 — Jan 2021 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
▶ Show 6 earlier versions
-
Sep 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE1 → NA
-
Jul 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- InSightec
For direct contact, visit the study record on ClinicalTrials.gov .